These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21740527)

  • 21. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis.
    Lin YT; Wang CT; Gershwin ME; Chiang BL
    Autoimmun Rev; 2011 Jun; 10(8):482-9. PubMed ID: 21320644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.
    Hall BM; Verma ND; Tran GT; Hodgkinson SJ
    Curr Opin Immunol; 2011 Oct; 23(5):641-7. PubMed ID: 21840184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of Treg cells in defective tumor immunity.
    Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy.
    Saito S; Nakashima A; Shima T; Ito M
    Am J Reprod Immunol; 2010 Jun; 63(6):601-10. PubMed ID: 20455873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, immunity, and hypertensive end-organ damage.
    McMaster WG; Kirabo A; Madhur MS; Harrison DG
    Circ Res; 2015 Mar; 116(6):1022-33. PubMed ID: 25767287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells: how do they suppress immune responses?
    Sakaguchi S; Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T
    Int Immunol; 2009 Oct; 21(10):1105-11. PubMed ID: 19737784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of apoptosis of CD4+ CD25+ regulatory T lymphocytes on polarization of helper T lymphocytes and potential interventional influence of Xuebijing injection in septic rats].
    Dai XG; Yao YM; Ai YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):135-8. PubMed ID: 19278580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
    Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
    J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of CD4+CD25+Foxp3+ regulatory T cells with anti-CD25 antibody may exacerbate the 1,3-β-glucan-induced lung inflammatory response in mice.
    Liu F; Weng D; Chen Y; Song L; Li C; Dong L; Wang Y; Tao S; Chen J
    Arch Toxicol; 2011 Nov; 85(11):1383-94. PubMed ID: 21347662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of T-regulatory cells in cord blood of atopic mothers.
    Schaub B; Liu J; Höppler S; Haug S; Sattler C; Lluis A; Illi S; von Mutius E
    J Allergy Clin Immunol; 2008 Jun; 121(6):1491-9, 1499.e1-13. PubMed ID: 18539197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of regulatory T-cell lineage.
    Hori S
    Adv Immunol; 2011; 112():1-24. PubMed ID: 22118405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual opposing roles of adaptive immunity in hypertension.
    Idris-Khodja N; Mian MO; Paradis P; Schiffrin EL
    Eur Heart J; 2014 May; 35(19):1238-44. PubMed ID: 24685711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Effects of Cytokines in Hypertension.
    Wen Y; Crowley SD
    Adv Exp Med Biol; 2019; 1165():443-454. PubMed ID: 31399978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune mechanisms in hypertension.
    De Ciuceis C; Rossini C; La Boria E; Porteri E; Petroboni B; Gavazzi A; Sarkar A; Rosei EA; Rizzoni D
    High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):227-34. PubMed ID: 24446309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal effects of cytokines in hypertension.
    Wen Y; Crowley SD
    Curr Opin Nephrol Hypertens; 2018 Mar; 27(2):70-76. PubMed ID: 29140820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.